Keywords: Out tratment, USA, Uric acid lowering therapy, Allopurinol, Uloric, Krystexxa, Decision Resources

Majority of gout patients on uric acid lowering therapy fail to achieve control of serum urate levels report

Article | 10 June 2012

Print This

While rheumatologists and primary care physicians (PCPs) in the USA recognize the importance of tight uric acid control as a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in